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Summary
A study was conducted to compare perfor-
mance, morbidity, retreatment percent, and
mortality in stressed heifer calves during the
receiving and growing phases after receiving
either Pyramid™ MLV 4 or Pyramid™
4+Presponse® SQ on arrival at a feedlot re-
search facility.  Vaccination with Pyramid
4+Presponse SQ (a 4-way viral modified live
vaccine with a Pasteurella haemolytica
bacterin-toxoid) tended to reduce the incidence
of bovine respiratory disease (P=.2) and re-
duced retreatment rate (P<.06).
Introduction
Respiratory disease has major economic
significance for the beef industry, with estimated
losses approaching $600 million annually. Ef-
forts to reduce the incidence of respiratory
disease have not resulted in major declines in
losses from this disease complex.  The produc-
tion and marketing systems  employed in the
beef industry can have a significant influence on
susceptibility to disease in confinement feeding
operations.  Viral vaccines are essential to
reducing the morbidity that occurs in calves
soon after arrival in feedlots.  Protecting against
this viral challenge should result in fewer pulls,
less mortality, and improved performance in the
first 28 days.
Pasteurella haemolytica serotype A1 is
the most commonly identified bacterial pathogen
involved in bovine respiratory disease early in
the receiving period.  Vaccination might abate
this challenge, thereby improving feed intake,
rate of gain and feed efficiency, while decreasing
the risk of death loss.  
The present study was conducted to evaluate
feed intake, weight gain, feed efficiency, mor-
bidity, retreatment percentage, and mortality of
heifers vaccinated using each of two modified
live vaccines, one of which contained the
Pasteurella haemolytica bacterin-toxoid.
Performance during the postreceiving period
also was evaluated.
Experimental Procedures
This study was conducted at the KSU Beef
Cattle Research Center in Manhattan, Kansas,
and was initiated on September 4, 1997.  The
receiving period was 28 days and was followed
by a growing period of 102 days.
Three hundred twenty four weaned heifer
calves (avg wt 500 lb) were purchased from
sale barns in Arkansas and trucked to  Man-
hattan.  Upon arrival at the feedlot, each load
was placed into a large pen and offered ad
libitum access to clean water and long-stem
prairie hay.  Approximately 24 hours after
arrival, weight and rectal temperature were
recorded for each heifer.  Heifers were worked
through the processing facility at random and
uniquely identified with numbered ear tags
during initial processing.  Each heifer was im-
planted with Synovex®-H and treated for inter-
nal and external parasites using Synanthic® oral
drench and CyLence® pour-on.  Additionally,
heifers were vaccinated against common
clostridial diseases using a subcutaneous injec-
tion of Fortress®-7.  Experimental treatments
consisted of subcutaneous injections of Pyramid
MLV 4 (4-way viral vaccine) or Pyramid
4+Presponse SQ (4-way viral plus Pasteurella
toxoid). During processing, heifers were sorted
by their respective treatments into groups of six
head, 
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with a total of 27 pens per vaccination treat-
ment. Groups were placed into partially cov-
ered, concrete surface pens (14’ × 28’) where
they were fed throughout the 28-day receiving
period and subsequent growing period.
Heifers were fed a common starter ration
during the receiving period.  Bunks were read at
approximately 6:00 a.m., at which time the
amount of feed to be offered at the next feeding
was determined.  Heifers were fed once daily.
Heifers that exhibited clinical signs of respi-
ratory disease, including depression, lethargy,
anorexia, coughing, rapid breathing, and nasal
and (or) ocular discharge, were identified each
morning. Morbid heifers received a subcutane-
ous injection of tilmicosin (Micotil®) at a dosage
of 1.5 ml/cwt and were returned to their original
pen.  When necessary, this treatment was
repeated after 48 hours. Therapy for third-time
treatments was a combination of Biomycin™
200 and Tylosin™ 200, administered intramus-
cularly at 6 and 5 ml/cwt, respectively.
Upon completion of the 28-day receiving
period, chronically ill and (or) lame animals
were removed from the experiment. The re-
maining calves were allotted, on a pen basis, to
each of nine dietary treatments in the subsequent
growing period.  Nutritional regimens were
applied uniformly across vaccination treatments,
thus making it possible to monitor growing
performance of the two vaccination treatments.
Results and Discussion
Performance and health data of the heifers
during the receiving and growing periods are
summarized in Table 1. Average dry matter
intake was similar (P=.28) for calves vaccinated
with Pyramid and Pyramid+Presponse.
L i k e w i s e ,  f e e d  e f f i c i e n c y
and daily gain were similar (P>.8) for the two
groups.  The percentage pulled and treated for
respiratory disease tended (P=.2) to be less
when heifers were vaccinated with
Pyramid+Presponse compared to Pyramid
alone.  Fewer animals required retreatment if
vaccinated with Pyramid+Presponse (P=.06).
The percentage of animals classified as chroni-
cally ill (i.e., three or more therapeutic treat-
ments) was not significantly different for the two
vaccine treatments (P=.22).   Mortality rate
(<2%) was not different for the two vaccine
treatments.  Vaccine treatment also had no
carryover effects on gain during the subsequent
growing period. 
Figure 1 illustrates the epidemic curve for
respiratory disease in heifers during the 28-day
receiving period.  The peak prevalence oc-
curred approximately 3 to 6 days after arrival in
the feedlot and followed a similar pattern for
Pyramid and Pyramid+Presponse groups.
Figure 2 shows the cumulative respiratory
morbidity percentage over the 28-day receiving
period.  The Pyramid+ Presponse heifers had
fewer pulls, especially earlier in the receiving
period (P<.1), but the responses converged
until day 23, at which time no statistical differ-
ence was found for the two treatments (P=.2).
Figure 3 illustrates the cumulative retreatments
for the two vaccine regimens.  By day 13 of the
study, a significant divergence of the two treat-
ments  had occurred,  with  the
Pyramid+Presponse heifers needing fewer
retreatments.
Although the Pyramid+Presponse treatment
tended to reduce morbidity and to statistically
improve retreatment percentage, performance
was not altered (Table 1).  We speculate that
performance and health responses to the two
vaccines might be different, if they were used in
stressed heifers that do not break with disease
until later in the receiving period.
Table 1.  Performance of Stressed Heifer Calves during the Receiving and
Growing Periods as Affected by Vaccine a
Item Pyramid @ MLV-4 Pyramid@-4 + Presponse SEM
Pens (head/pen) 27 (6) 27 (6)
Initial weight, lb 496.3 495.2
Dry matter intake, lb/day 9.2 9.5
Feed efficiency 6.15 5.84
Gain, lb/day 1.60 1.66
Gain, lb/day (deads out) 2.07 2.03
Pulls, % 46.3 37.0
Retreats, %b 10.5 4.3
Chronics, % 4.3 1.85
Deads, % 1.85   1.85
2.8
.2
.94
.24
.12
4.7
2.3
1.4
1.1
Growing gain, lb/day
(deads & chronics removed) 1 .60   1.57 .04
a Least-squares means.
b Pyramid different than Pyramid +Presponse, P<.06.
Pyramid
Pyramid+Presponse
Figure 1. Animals Pulled for Respiratory Disease vs. Days after Arrival.
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Figure 2. Cumulative Percent of Animals Pulled for Respiratory Disease vs. Days after
Arrival.
Figure 3. Cumulative Retreatment Percentage.
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